How would you define a specialty pharmaceutical? Chances are, it’s different from the way another healthcare executive would define them.
Pharmacy Best Practices
The hope is that more biosimilars will lead to more access and more affordable medications, but biosimilar uptake is lagging. Here’s why and how FDA hopes to fix it.
FDA issued a recall of popular blood pressure drugs. Here’s what you need to know.
Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.
Not all therapies work the same in every patient, but that’s not the biggest challenge in treating mental health. This is.
In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.
A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.
Here are four other things that MCOs should know about a first-of-its kind targeted RNA-based therapy to treat a rare disease.
Although the act would not prohibit manufacturers from increasing prices, it could change the pricing landscape. Here’s why.
Managed Healthcare Executive asked key opinion leaders their thoughts on the drug rebate controversy. Here’s what they said.